S. Cheng

发表

All-trans Retinoic Acid combined with oxaliplatin suppressed proliferation of chemo-resistant hepatocellular carcinoma cells by inducing G2/M cell cycle arrest

Jie Shi, Zongtao Chai, Ju-xian Sun, 2021, Archives of Medical Science.

Transarterial chemoembolization plus a PD‐1 inhibitor with or without lenvatinib for intermediate‐stage hepatocellular carcinoma

Kang Wang, Y. Shan, Yuqiang Cheng, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

Transcatheter arterial chemoembolization plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: a single-arm, phase 2 trial.

Kang Wang, Jie Shi, Wei-xing Guo, 2022, Future oncology.

Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.

P. Thall, G. Hortobagyi, R. Giles, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Radiotherapy prior to or after transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a randomized controlled trial

Wei-xing Guo, Jie Shi, Wanyee Lau, 2022, Hepatology International.

The A-to-I editing of KPC1 promotes intrahepatic cholangiocarcinoma by attenuating proteasomal processing of NF-κB1 p105 to p50

Yiming Lu, Yuanfeng Li, Gangqiao Zhou, 2022, Journal of Experimental & Clinical Cancer Research.

Alpha-1-fucosidase as a prognostic indicator for hepatocellular carcinoma following hepatectomy: a large-scale, long-term study

W. Lau, K. Wang, N. Li, 2014, British Journal of Cancer.

Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis

D. Xie, Hui-Jun Cao, Kang Wang, 2021, Oncogene.

GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers

Hongbing Shen, Xinchun Chen, Boping Zhou, 2012, PLoS genetics.

Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma

D. Xie, Nan Li, Jie Xue, 2010, British Journal of Cancer.

Prognostic Value of Microvascular Invasion in Eight Existing Staging Systems for Hepatocellular Carcinoma: A Bi-Centeric Retrospective Cohort Study

Kang Wang, Y. Shan, Yuqiang Cheng, 2021, Frontiers in Oncology.